Multiple sclerosis drug tied to rising JC virus antibody levels
Thursday, January 28, 2016 - 11:04
in Health & Medicine
People who take the drug natalizumab for multiple sclerosis may have up to a 10 times greater risk of developing a risk biomarker for activity of a virus that can lead to an often fatal brain disease, according to a study.